These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Papaverine-induced priapism. Experiences with a new urologic emergency]. Schneider AW; Busch R; Gonnermann D; Klosterhalfen H Dtsch Med Wochenschr; 1989 Feb; 114(6):214-7. PubMed ID: 2917481 [TBL] [Abstract][Full Text] [Related]
5. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients. Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363 [TBL] [Abstract][Full Text] [Related]
7. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients. Fu Q; Yao DH; Jiang YQ Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421 [TBL] [Abstract][Full Text] [Related]
8. Intracavernous self-injection pharmacotherapy program: analysis of results and complications. Valdevenito R; Melman A Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702 [TBL] [Abstract][Full Text] [Related]
9. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. Dinsmore WW Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115 [TBL] [Abstract][Full Text] [Related]
10. [Prostaglandin E1 in erectile dysfunction]. Porst H Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258 [TBL] [Abstract][Full Text] [Related]
11. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections. Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intracavernous pharmacotherapy. Sidi AA Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756 [TBL] [Abstract][Full Text] [Related]
13. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy. McMahon CG Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142 [No Abstract] [Full Text] [Related]
14. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]
15. Priapism: an avoidable complication of pharmacologically induced erection. Fouda A; Hassouna M; Beddoe E; Kalogeropoulos D; Binik YM; Elhilali MM J Urol; 1989 Oct; 142(4):995-7. PubMed ID: 2795759 [TBL] [Abstract][Full Text] [Related]
16. [Corpus cavernosum injection treatment of erectile impotence]. Lenk S; Schönherr G; Korner I Z Urol Nephrol; 1990 Oct; 83(10):539-46. PubMed ID: 2095661 [TBL] [Abstract][Full Text] [Related]
17. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
18. [Priapism as a complication of the treatment of impotence by local injections of papaverine]. Kaczmarek A Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150 [TBL] [Abstract][Full Text] [Related]
19. [Priapism as a complication following diagnostic papaverine test]. Darewicz J; Galek L Z Urol Nephrol; 1989 Jun; 82(6):317-9. PubMed ID: 2763728 [TBL] [Abstract][Full Text] [Related]